Aditxt, Inc. (ADTX), a biopharmaceutical company, announced that Amro Albanna, the Chief Executive Officer and Co-founder, has resigned and has appointed Jeffrey M. Busch as the interim Chief Executive Officer, effective May 31, 2026.
Busch brings experience as the founder, Chairman, and former Chief Executive Officer of Global Medical REIT, Inc., now Chiron Real Estate, Inc.
He succeeds the position, after serving as the CEO of Aditxt's CLIA-certified precision oncology diagnostics subsidiary Ignite Proteomics, LLC since March 2026.
ADTX is currently trading down 9.98% to $0.10.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.